Land: Storbritannien
Språk: engelska
Källa: MHRA (Medicines & Healthcare Products Regulatory Agency)
Lercanidipine hydrochloride
Arrow Generics Ltd
C08CA13
Lercanidipine hydrochloride
20mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02060200; GTIN: 5060034834793
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT LERCANIDIPINE HYDROCHLORIDE 10 MG FILM-COATED TABLETS LERCANIDIPINE HYDROCHLORIDE 20 MG FILM-COATED TABLETS lercanidipine hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. IN THIS LEAFLET: 1. What Lercanidipine Hydrochloride is and what it is used for 2. What you need to know before you take Lercanidipine Hydrochloride 3. How to take Lercanidipine Hydrochloride 4. Possible side effects 5. How to store Lercanidipine Hydrochloride 6. Contents of the pack and other information 1. WHAT LERCANIDIPINE HYDROCHLORIDE IS AND WHAT IT IS USED FOR Lercanidipine Hydrochloride belongs to a group of medicines called calcium channel blockers that block the entry of calcium into the muscle cells of the heart and the blood vessels that carry blood away from the heart (the arteries). It is the entry of calcium into these cells that causes the heart to contract and arteries to narrow. By blocking the entry of calcium, calcium channel blockers decrease contraction of the heart and dilate (widen) the arteries, and the blood pressure is reduced. This medicine has been prescribed to you to treat your high blood pressure, also known as hypertension. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE LERCANIDIPINE HYDROCHLORIDE DO NOT TAKE LERCANIDIPINE HYDROCHLORIDE • if you are allergic to lercanidipine or to any of the ingredients in this medicine (listed in section 6) • if you have had allergic reactions to medicines that are closely related to lercanidipine (such as amlodipine, nicardipine, Läs hela dokumentet
OBJECT 1 LERCANIDIPINE HYDROCHLORIDE 20 MG FILM-COATED TABLETS (ARROW) Summary of Product Characteristics Updated 21-Jan-2014 | Accord-UK Ltd 1. Name of the medicinal product Lercanidipine hydrochloride 20 mg Film-coated Tablets 2. Qualitative and quantitative composition One film-coated tablet contains 20 mg lercanidipine hydrochloride, equivalent to 18.8 mg lercanidipine. Excipient: Each lercanidipine hydrochloride 20 mg film-coated tablet contains 60 mg lactose monohydrate, 0.018 mg Sunset Yellow (E110) and 0.012 mg Allura Red (E129). For a full list of excipients, see section 6.1 3. Pharmaceutical form Film-coated tablet (tablet). Pink, round shaped coated tablet, with bisect on one side and 'LC' over ' ' on the other side. The tablet can be divided into equal halves. 4. Clinical particulars 4.1 Therapeutic indications Lercanidipine hydrochloride 20 mg Film-coated Tablets are indicated for the treatment of mild to moderate essential hypertension. 4.2 Posology and method of administration The recommended dosage is 10 mg once a day to be taken orally at least 15 minutes before a meal; the dose may be increased to 20 mg depending on the individual patient's response. Dose titration should be gradual; it may take 2 weeks before the maximal antihypertensive effect is apparent. Some individuals, not adequately controlled on a single antihypertensive agent, may benefit from the addition of lercanidipine to therapy with a beta-adrenoreceptor blocking drug (atenolol), a diuretic (hydrochlorothiazide) or an angiotensin converting enzyme inhibitor (captopril or enalapril). Since the dose-response curve is steep with a plateau at doses between 20-30 mg, it is unlikely that efficacy will be improved by higher doses; whereas side effects may increase. USE IN THE ELDERLY Although the pharmacokinetic data and clinical experience suggest that no adjustment of the daily dosage is required, special care should be exercised when initiating treatment in the elderly. USE IN CHILDREN AND ADOLESCENTS Lercanidipine is not recommended Läs hela dokumentet